M&A deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable M&A deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured M&A deals

All M&A deals: Deal Monitor | Current Agreements

Valeant ups offer and secures Salix; Endo withdraws

March 17, 2015 : big pharma, M&A, Valeant

Valeant increased the offer price to acquire all the outstanding common stock of Salix from $158.00 per share to $173.00 per share more »

GlaxoSmithKline sells Aspen Pharmacare $853 million equity stake

March 16, 2015 : big pharma, GlaxoSmithKline, M&A

GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings more »

Endo makes counter bid for Salix

March 12, 2015 : big pharma, M&A

Endo International has submitted a proposal to the Board of Directors of Salix to acquire all of the outstanding shares of common stock of Salix Pharmaceuticals more »

Concordia Healthcare stumps up $1.2bn for Covis Pharma assets

March 10, 2015 : asset purchase, M&A, partnering

Concordia Healthcare has entered into a definitive asset purchase agreement to acquire substantially all of the commercial assets of privately held Covis Pharma and Covis Injectables for US$1.2 billion more »

Abbvie acquires Pharmacyclics for $21 billion

March 9, 2015 : AbbVie, big pharma, M&A

AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica (ibrutinib), a highly effective treatment for hematologic malignancies more »

Mallinckrodt acquires Ikaria for $2.3bn

March 5, 2015 : M&A

Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion more »

Baxter acquires Suppremol for $225 million

March 5, 2015 : Baxter, big pharma, M&A

Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments more »

Nikon acquires Optos for $400 million

March 2, 2015 : M&A, medical device

Nikon has agreed to buy British retinal imaging firm Optos for 259.3 million pounds more »

Shire acquires Meritage Pharma for $70 million

February 26, 2015 : M&A, shire

Shire has acquired Meritage for an upfront fee of $70 million and additional contingent payments more »

Sorin and Cyberonics to merge

February 26, 2015 : M&A

Sorin and Cyberonics announced their merger plan to create a new global leader in medical technologies more »

« Page 1, 2, 3, 4 ... 65, »

Derived from Current Agreements, more featured partnering deals by category:

Big pharma

AstraZeneca and Innate Pharma in IPH2201 deal

April 28, 2015

Celgene and AstraZeneca in MEDI4736 pact

April 28, 2015

Teva bids to acquire Mylan as Perrigo rejects approach

April 22, 2015

View more featured deals | all deals at Deal Monitor

Big biotech

Athersys and Chugai announce pharma licensing deal for ischemic stroke

March 3, 2015

Teva enters into pharma licensing deal with Eagle Pharmaceuticals for cancer drug

February 18, 2015

Genzyme and Voyager in $845 million AAV gene therapy pact

February 12, 2015

View more featured deals | all deals at Deal Monitor


Lilly snags rights to Erbitux from BMS

April 20, 2015

Ventana and Astellas in automated tissue diagnostics pact

April 15, 2015

Janssen and Ichor Medical enter hep B vaccine delivery alliance

April 14, 2015

View more featured deals | all deals at Deal Monitor


Curis and Aurigene in immuno-oncology pact

January 22, 2015

Agile Therapeutics bags $20 million in private placement

January 21, 2015

Celgene licenses AG-120 from Agios

January 14, 2015

View more featured deals | all deals at Deal Monitor


LabCorp has acquired Covance for $6.1 billion

November 4, 2014

Qiagen and Astellas form a biotech partnership to develop companion diagnostics

October 30, 2014

In m&a news: Optum has bought Alere Health for $600 million

October 30, 2014

View more featured deals | all deals at Deal Monitor

Medical device

BTG acquires emphysema innovator PneumRx

December 5, 2014

Conventus Orthopaedics banks series AA financing for $24 million

December 4, 2014

Xeltis secures series B financing for $34 million

December 3, 2014

View more featured deals | all deals at Deal Monitor

Drug delivery

M&A news: Acorda has purchased Civitas Therapeutics

September 25, 2014

NeuroDerm files for $250 million in IPO financing

September 17, 2014

Foamix Pharma files for $75 million in IPO financing

August 15, 2014

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email